Plasminogen Activation System and Fibroblasts: Impact on Tissue Remodeling, Disease, and Organ Homeostasis. [PDF]
Moideen FM, Bhandary YP.
europepmc +1 more source
Beyond Fibrinolysis: Urokinase Plasminogen Activator as an Early Regulator of Obesity. [PDF]
Torrente D, Strickland S.
europepmc +1 more source
Elevated Soluble Urokinase-Type Plasminogen Activator Receptor Levels, Organ Dysfunction, and Death in Children Hospitalized With Malaria: Considerations for Use as a Risk Stratification Tool. [PDF]
Ssuuna C +11 more
europepmc +1 more source
Maternal soluble urokinase plasminogen activator receptor levels in intrahepatic cholestasis of pregnancy: a predictor of neonatal intensive care unit admission. [PDF]
Aktaş BA +7 more
europepmc +1 more source
Soluble Urokinase-type Plasminogen Activator Receptor (suPAR) as a Biomarker of Neurodysfunction. [PDF]
de Rezende VL +4 more
europepmc +1 more source
Transdiagnostic determinants of Growth Differentiation Factor-15 (GDF-15) in psychiatric in-patients: age, renal indices, interleukin-6 (IL-6) and soluble urokinase plasminogen activator receptor (suPAR). [PDF]
Tsapakis EM +8 more
europepmc +1 more source
Serum profiling of uPA, PAI-1, and suPAR in systemic sclerosis: a preliminary study on analytical aspects and associations with microvascular and fibrotic manifestations. [PDF]
Napolitano F +5 more
europepmc +1 more source
Select novel small-molecule uPA potential inhibitors as anti-cancer agents against breast cancer. [PDF]
Almosnid N +11 more
europepmc +1 more source
Urokinase Promotes Redundantly Intratubular C3a-Formation But Not ENaC-Driven Hypertension in DOCA/Salt Kidney Injury. [PDF]
Bach ML +6 more
europepmc +1 more source
Modeling the role of urokinase-type plasminogen activator, uPA, and circulating cancer-associated fibroblasts (cCAFs) in breast cancer cell extravasation. [PDF]
Spartz A +5 more
europepmc +1 more source

